| 4601 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
58 |
| 4602 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
67 |
| 4603 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
47 |
| 4604 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
56 |
| 4605 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
55 |
| 4606 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
64 |
| 4607 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
66 |
| 4608 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
65 |
| 4609 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
63 |
| 4610 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
69 |
| 4611 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
63 |
| 4612 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2020
|
Standard Therapy
|
Germany
|
73 |
| 4613 |
Apheresis |
Allogeneic
|
Myelofibrosis
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
63 |
| 4614 |
Apheresis |
Allogeneic
|
Myelofibrosis With Myeloid Metaplasia
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
69 |
| 4615 |
Apheresis |
Allogeneic
|
Myelofibrosis With Myeloid Metaplasia
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
70 |
| 4616 |
Apheresis |
Allogeneic
|
Myelofibrosis With Myeloid Metaplasia
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
63 |
| 4617 |
Apheresis |
Allogeneic
|
Myelofibrosis With Myeloid Metaplasia
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
62 |
| 4618 |
Apheresis |
Allogeneic
|
Myelofibrosis With Myeloid Metaplasia
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
43 |
| 4619 |
Apheresis |
Allogeneic
|
Myeloma Multiplex
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
63 |
| 4620 |
Apheresis |
Allogeneic
|
Myeloma Multiplex
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
52 |
| 4621 |
Apheresis |
Allogeneic
|
Myeloproliferative Neoplasms
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
68 |
| 4622 |
Apheresis |
Allogeneic
|
Myeloproliferative Neoplasms
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
40 |
| 4623 |
Apheresis |
Allogeneic
|
No Data
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
71 |
| 4624 |
Apheresis |
Allogeneic
|
No Data
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
64 |
| 4625 |
Apheresis |
Allogeneic
|
Non-Hodgkin Lymphoma
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
65 |
| 4626 |
Apheresis |
Allogeneic
|
Non-Hodgkin Lymphoma
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
58 |
| 4627 |
Apheresis |
Allogeneic
|
Non-Hodgkin Lymphoma
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
63 |
| 4628 |
Apheresis |
Allogeneic
|
Non-Hodgkin Lymphoma
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
58 |
| 4629 |
Apheresis |
Allogeneic
|
Non-Hodgkin Lymphoma
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
62 |
| 4630 |
Apheresis |
Allogeneic
|
Non-Hodgkin Lymphoma
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
53 |
| 4631 |
Apheresis |
Allogeneic
|
Non-Hodgkin Lymphoma
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
57 |
| 4632 |
Apheresis |
Allogeneic
|
Non-Hodgkin Lymphoma
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
69 |
| 4633 |
Apheresis |
Allogeneic
|
Non-Hodgkin Lymphoma
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
62 |
| 4634 |
Apheresis |
Allogeneic
|
Non-Hodgkin Lymphoma
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
34 |
| 4635 |
Apheresis |
Autologous
|
Non-Hodgkin Lymphoma
|
Hematology
|
2020
|
Standard Therapy
|
Germany
|
42 |
| 4636 |
Apheresis |
Allogeneic
|
Non-Hodgkin Lymphoma
|
Hematology
|
2020
|
Standard Therapy
|
Germany
|
62 |
| 4637 |
Apheresis |
Autologous
|
Non-Hodgkin-Lymphoma-Relapse
|
Hematology
|
2020
|
Standard Therapy
|
Germany
|
56 |
| 4638 |
Apheresis |
Autologous
|
Non-Hodgkin-Lymphoma-Relapse
|
Hematology
|
2020
|
Standard Therapy
|
Germany
|
67 |
| 4639 |
Apheresis |
Allogeneic
|
Osteomyelofibrosis
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
68 |
| 4640 |
Apheresis |
Allogeneic
|
Osteomyelofibrosis
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
52 |
| 4641 |
Apheresis |
Allogeneic
|
Osteomyelofibrosis
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
64 |
| 4642 |
Apheresis |
Allogeneic
|
Paroxysmal Nocturnal Hemoglobinuria (Pnh)
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
57 |
| 4643 |
Apheresis |
Allogeneic
|
Perforin Deficiency
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
2 |
| 4644 |
Apheresis |
Autologous
|
Primary Central Nervous System Lymphoma
|
Hematology
|
2020
|
Standard Therapy
|
Germany
|
59 |
| 4645 |
Apheresis |
Autologous
|
Primary Cerebral Diffuse Large B-Cell Lymphoma
|
Hematology
|
2020
|
Standard Therapy
|
Germany
|
66 |
| 4646 |
Apheresis |
Autologous
|
Primary Cerebral Diffuse Large B-Cell Lymphoma
|
Hematology
|
2020
|
Standard Therapy
|
Germany
|
59 |
| 4647 |
Apheresis |
Allogeneic
|
Primary Myelofibrosis
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
63 |
| 4648 |
Apheresis |
Allogeneic
|
Primary Myelofibrosis
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
61 |
| 4649 |
Apheresis |
Allogeneic
|
Primary Myelofibrosis
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
51 |
| 4650 |
Apheresis |
Allogeneic
|
Primary Myelofibrosis
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
66 |
| 4651 |
Apheresis |
Allogeneic
|
Primary Myelofibrosis
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
61 |
| 4652 |
Apheresis |
Allogeneic
|
Primary Myelofibrosis
|
Hematology
|
2020
|
Standard Therapy
|
Germany
|
54 |
| 4653 |
Apheresis |
Allogeneic
|
Primary Myelofibrosis
|
Hematology
|
2020
|
Standard Therapy
|
Germany
|
58 |
| 4654 |
Apheresis |
Allogeneic
|
Purine Nucleoside Phosphorylase Deficiency
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
1 |
| 4655 |
Apheresis |
Allogeneic
|
Secondary Acute Myeloid Leukemia
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
43 |
| 4656 |
Apheresis |
Allogeneic
|
Secondary Acute Myeloid Leukemia
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
76 |
| 4657 |
Apheresis |
Allogeneic
|
Secondary Acute Myeloid Leukemia
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
57 |
| 4658 |
Apheresis |
Allogeneic
|
Secondary Acute Myeloid Leukemia
|
Hematology
|
2020
|
Standard Therapy
|
Germany
|
66 |
| 4659 |
Apheresis |
Allogeneic
|
Secondary Acute Myeloid Leukemia
|
Hematology
|
2020
|
Standard Therapy
|
Germany
|
56 |
| 4660 |
Apheresis |
Autologous
|
Secondary B-Cell Non-Hodgkin-Lymphoma
|
Hematology
|
2020
|
Standard Therapy
|
Germany
|
73 |
| 4661 |
Apheresis |
Autologous
|
Secondary Diffuse Large B-Cell Lymphoma
|
Hematology
|
2020
|
Standard Therapy
|
Germany
|
54 |
| 4662 |
Apheresis |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
9 |
| 4663 |
Apheresis |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
53 |
| 4664 |
Apheresis |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
52 |
| 4665 |
Apheresis |
Allogeneic
|
Severe Combined Immunodeficiency
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
2 |
| 4666 |
Apheresis |
Allogeneic
|
Sezary Syndrome
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
44 |
| 4667 |
Apheresis |
Allogeneic
|
T-Cell Acute Lymphoblastic Leukemia
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
14 |
| 4668 |
Apheresis |
Autologous
|
T-Cell Non-Hodgkin Lymphoma
|
Hematology
|
2020
|
Standard Therapy
|
Germany
|
57 |
| 4669 |
Apheresis |
Autologous
|
T-Cell Non-Hodgkin Lymphoma
|
Hematology
|
2020
|
Standard Therapy
|
Germany
|
29 |
| 4670 |
Apheresis |
Autologous
|
T-Cell Non-Hodgkin Lymphoma
|
Hematology
|
2020
|
Standard Therapy
|
Germany
|
64 |
| 4671 |
Apheresis |
Allogeneic
|
T-Cell Non-Hodgkin Lymphoma
|
Hematology
|
2020
|
Standard Therapy
|
Germany
|
63 |
| 4672 |
Apheresis |
Allogeneic
|
T-Cell-Lymphoma
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
29 |
| 4673 |
Apheresis |
Autologous
|
T-Cell-Lymphoma
|
Hematology
|
2020
|
Standard Therapy
|
Germany
|
51 |
| 4674 |
Apheresis |
Autologous
|
T-Cell-Lymphoma
|
Hematology
|
2020
|
Standard Therapy
|
Germany
|
60 |
| 4675 |
Apheresis |
Allogeneic
|
T-Cell-Prolymphocytic Leukemia
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
55 |
| 4676 |
Apheresis |
Allogeneic
|
T-Cell-Prolymphocytic Leukemia
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
74 |
| 4677 |
Apheresis |
Allogeneic
|
Β – Thalassemia
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
6 |
| 4678 |
Apheresis |
Allogeneic
|
Β – Thalassemia Major
|
Hematology
|
2020
|
Standard Therapy
|
Poland
|
17 |
| 4679 |
Adipose Tissue |
Autologous
|
Alopecia
|
Dermatology
|
2020
|
Experimental Therapy
|
Poland
|
68 |
| 4680 |
Adipose Tissue |
Autologous
|
Chondromalacia
|
Orthopedy
|
2020
|
Experimental Therapy
|
Poland
|
45 |
| 4681 |
Adipose Tissue |
Autologous
|
Gonarthrosis
|
Orthopedy
|
2020
|
Experimental Therapy
|
Poland
|
52 |
| 4682 |
Adipose Tissue |
Autologous
|
Gonarthrosis
|
Orthopedy
|
2020
|
Experimental Therapy
|
Poland
|
63 |
| 4683 |
Adipose Tissue |
Autologous
|
Gonarthrosis
|
Orthopedy
|
2020
|
Experimental Therapy
|
Poland
|
41 |
| 4684 |
Adipose Tissue |
Autologous
|
Gonarthrosis
|
Orthopedy
|
2020
|
Experimental Therapy
|
Poland
|
34 |
| 4685 |
Adipose Tissue |
Autologous
|
Gonarthrosis
|
Orthopedy
|
2020
|
Experimental Therapy
|
Poland
|
48 |
| 4686 |
Adipose Tissue |
Autologous
|
Gonarthrosis
|
Orthopedy
|
2020
|
Experimental Therapy
|
Poland
|
57 |
| 4687 |
Adipose Tissue |
Autologous
|
Gonarthrosis
|
Orthopedy
|
2020
|
Experimental Therapy
|
Poland
|
59 |
| 4688 |
Adipose Tissue |
Autologous
|
Gonarthrosis
|
Orthopedy
|
2020
|
Experimental Therapy
|
Poland
|
35 |
| 4689 |
Adipose Tissue |
Autologous
|
Gonarthrosis
|
Orthopedy
|
2020
|
Experimental Therapy
|
Poland
|
61 |
| 4690 |
Adipose Tissue |
Autologous
|
Gonarthrosis
|
Orthopedy
|
2020
|
Experimental Therapy
|
Poland
|
56 |
| 4691 |
Adipose Tissue |
Autologous
|
Gonarthrosis; Shoulder Osteoarthritis
|
Orthopedy
|
2020
|
Experimental Therapy
|
Poland
|
42 |
| 4692 |
Adipose Tissue |
Autologous
|
Internal Damage To The Knee Joint
|
Orthopedy
|
2020
|
Experimental Therapy
|
Poland
|
53 |
| 4693 |
Adipose Tissue |
Autologous
|
Internal Damage To The Knee Joint
|
Orthopedy
|
2020
|
Experimental Therapy
|
Poland
|
49 |
| 4694 |
Adipose Tissue |
Autologous
|
Omarthrosis
|
Orthopedy
|
2020
|
Experimental Therapy
|
Poland
|
70 |
| 4695 |
Adipose Tissue |
Autologous
|
Other Acquired Deformities Of The Ankle And Foot
|
Orthopedy
|
2020
|
Experimental Therapy
|
Poland
|
41 |
| 4696 |
Adipose Tissue |
Autologous
|
Scar
|
Dermatology
|
2020
|
Clinical Trial
|
Poland
|
0 |
| 4697 |
Adipose Tissue |
Autologous
|
Soft Tissue Diseases Related To Use, Overload And Pressure
|
Orthopedy
|
2020
|
Experimental Therapy
|
Poland
|
61 |
| 4698 |
Cord Tissue |
Allogeneic – Unrelated
|
Limb-Girdle Muscular Dystrophy
|
Neurology
|
2019
|
Experimental Therapy
|
Poland
|
5 |
| 4699 |
Cord Tissue |
Allogeneic – Unrelated
|
Acute Graft Versus Host Disease
|
Hematology
|
2019
|
Experimental Therapy
|
Poland
|
1 |
| 4700 |
Cord Tissue |
Allogeneic – Unrelated
|
Acute Graft Versus Host Disease
|
Hematology
|
2019
|
Experimental Therapy
|
Poland
|
6 |